2021 International Symposium on Treatment of Brain and Neurology Disorders

2021 International Symposium on Treatment of Brain and Neurology Disorders 　|　Web view

The brain is the most complex and mysterious organ in the human body. In the 21st century, when technology is advancing by leaps and bounds, the mystery of "brain science" has attracted countless scientists making all-out effort to decipher the code, analyze the mechanism of action, and deconstruct the brain in-depth in the hope of eliminating neurological brain diseases and creating human welfare.

To promote the breakthrough of brain technology and the R&D process innovation of neurological brain diseases, the Ministry of Science and Technology (MoST) has organized the "2021 International Symposium on Treatment of Brain and Neurology Disorders". In this event, global assembly of reputable researchers, medical KOLs, industrial parties including European biotechs and active Taiwanese tech investors facilitate the mutual advancement of the latest therapeutic progress of neurological brain disorders at a hybrid symposium for on-site and on-line audiences. In addition, the symposium will comprehensively gather remarkable R&D results and clinical applications to inspire brain technology development and create innovative business model through multidisciplinary integration.

In this international symposium, we will discuss：


•	Neurological Brain Diseases: clinical applications of mechanistic research, unsolved illness, and innovative therapies

•	Brainscience Business Opportunities: business models such as development trends, unmet medical needs, and collaboration & licensing

Information

Date
October 5, 2021 (Tuesday)

Time
13:30 PM － 17:30 PM (GMT+8)
(13:00 Guest Reception)

Location
GIS NTU Meeting Center –
Room Socrates

Address
B1, No. 85, Sec. 4, Roosevelt Rd., Da’an Dist., Taipei City, Taiwan (R.O.C.)

Agenda


Time	Agenda	Speaker
13:00-13:30	Registration
13:30-13:35	Opening Remarks : Bridge between Taiwanese and European Brain-Neuro science	Dr. Hong-Chen Chen 陳鴻震 Director, Department of Life Sciences, MoST
13:35-13:40	Photo Call
13:40-13:50	Innovative Brain : Strategy for Brain Science Development in Taiwan	Dr. Julie Y.H. Chan 華瑜 Institute for Translational Research in Biomedicine, Cheng Gung Memorial Hospital
13:50-14:20	Keynote Speech : How do Innovation Hubs in Europe Translate Their Ideas into Business, especially for CNS	GM : Dr. Henk Joos Agio Capital & Business Solutions
14:20-14:50	Noninvasive Focused Ultrasound Induced CNS Intervention	Dr. Hao-Li Liu 劉浩澧 Department of Electrical Engineering, National Taiwan University
14:50-15:20	Disease-modifying Treatments for Patients Suffering from Protein-misfolding Disorders	Study Director : Dr. Sofie Carmans Degeneration treatment company: reMYND NV
15:20-15:30	Coffee break
15:30-16:00	Decoding Brain and Genetic Signatures of Migraine	Dr. Shih-Pin Chen M.D., PhD 陳世彬 Institute of Neuroscience, National Yang Ming Chiao Tung University
16:00-16:30	Potential Therapeutic Vaccines for Autoimmune Myasthenia Gravis	CEO : Dr. Stéphane Huberty M.D., Ph.D. Therapeutic vaccine company: CuraVac, Inc.
16:30-17:00	Research on Intelligent Adaptive Deep Brain Stimulation System for Precise Treatment of Parkinson’s Disease	Dr. Ming-Dou Ker 柯明道 Biomedical Electronics Translational Research Center (BETRC), National Yang Ming Chiao Tung University
17:00-17:30	Next-generation Medicines on Neuroprotection for Brain Diseases	CSO: Dr. Pablo Villoslada M.D., Ph.D. CNS treatment company: Accure Therapeutics
17:30	Closing